Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Machine Learning Aids Identification of Large Vessel Occlusions

By HospiMedica International staff writers
Posted on 21 Dec 2020
A 3D convolutional neural network (CNN) helps find large-vessel occlusions (LVOs) on head and neck CT angiography (CTA) exams, according to a new study.

Researchers at Rhode Island Hospital (Providence, USA) conducted a study to assess the performance of a deep learning (DL) algorithm in identifying LVOs on CTA studies. More...
To do say, they trained the CNN with more than 7,000 exams for LVO, and tested it on a set that consisted of 10% of these same exams, which were classified into three categories: no LVO (83.5%); chronic LVO (13.6%); and acute LVO (2.9%). The researchers also used 683 positive LVO studies as an independent test set.

Using CTA, it is possible to demonstrate the anatomy of the aortic arch, carotid, and cerebral arteries, stenosis/thrombus of carotid or cerebral arteries, and an impression of the functioning collateral network. Lack of enhancement also provides an estimate of the cerebral blood flow reduction. The results of the study showed that the CNN had a 96% accuracy rate and a 5% false-positive rate for categorizing LVOs. The study was presented at the Radiological Society of North America (RSNA) 106th Scientific Assembly and Annual Meeting, held online during November 2020.

“Almost 800,000 people in the United States have a stroke each year, and about 10% of those are due to large-vessel occlusions. Time is brain, so getting patients treated sooner will help them retain more neurologic function,” said lead author and presenter Ian Pan, MD. “3D CNNs were effective in identifying series of interest and acute LVOs in CT angiography. At a five percent false-positive rate, over 40% of acute LVOs would be successfully identified without manual intervention.”

Advanced AI imaging analysis will enable first responders to bypass emergency departments and take patients directly to an endovascular catheterization laboratory, the operating room, a hospital stroke unit, or the neuro-intensive care unit to provide immediate treatment, including administration of tissue plasminogen activator (tPA) and the potent blood pressure drug nicardipine.

Related Links:
Rhode Island Hospital


Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Enteral Feeding Pump
SENTINELplus
X-Ray System
Leonardo DR mini III
Infant Incubator
OKM 801
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.